D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
OPK holding history
Opko Health, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OPK overviewAll 13F holders of OPKFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −4,731,688−100.0% | Sold out | Holders |
| Q1 2025 | 4,731,688 | $7.85M | <0.1% | +4,731,688 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −2,646,084−100.0% | Sold out | Holders |
| Q1 2024 | 2,646,084 | $3.18M | <0.1% | −3,196,453−54.7% | Reduced | Holders |
| Q4 2023 | 5,842,537 | $8.82M | <0.1% | −320,902−5.2% | Reduced | Holders |
| Q3 2023 | 6,163,439 | $9.86M | <0.1% | +460,014+8.1% | Added | Holders |
| Q2 2023 | 5,703,425 | $12.4M | <0.1% | +431,454+8.2% | Added | Holders |
| Q1 2023 | 5,271,971 | $7.70M | <0.1% | −514,206−8.9% | Reduced | Holders |
| Q4 2022 | 5,786,177 | $7.23M | <0.1% | −182,129−3.1% | Reduced | Holders |
| Q3 2022 | 5,968,306 | $11.3M | <0.1% | −397,910−6.3% | Reduced | Holders |
| Q2 2022 | 6,366,216 | $16.1M | <0.1% | +990,990+18.4% | Added | Holders |
| Q1 2022 | 5,375,226 | $18.5M | <0.1% | +1,294,225+31.7% | Added | Holders |
| Q4 2021 | 4,081,001 | $19.6M | <0.1% | +2,003,147+96.4% | Added | Holders |
| Q3 2021 | 2,077,854 | $7.58M | <0.1% | −478,728−18.7% | Reduced | Holders |
| Q2 2021 | 2,556,582 | $10.4M | <0.1% | −979,049−27.7% | Reduced | Holders |
| Q1 2021 | 3,535,631 | $15.2M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.